Angela DeMichele

发表

Computer aided automatic detection of malignant lesions in diffuse optical mammography.

Wensheng Guo, Regine Choe, Turgut Durduran, 2010, Medical physics.

Working at the Boundary: A Meta Analysis of Boundary Spanning and Team Performance

Daniel Slyngstad, Angela DeMichele, Maritza R. Salazar, 2017 .

Quantification of tumor changes during neoadjuvant chemotherapy with longitudinal breast DCE-MRI registration

Christos Davatzikos, Jia Wu, Mark Rosen, 2015, Medical Imaging.

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Artemis G. Hatzigeorgiou, Victor A. Simossis, Praveen Sethupathy, 2008, Proceedings of the National Academy of Sciences.

Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.

David Wholley, Anne Wallace, Michael Hogarth, 2012, Journal of Clinical Oncology.

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.

Donald A. Berry, Nola M. Hylton, Rita Nanda, 2017 .

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer

Angela DeMichele, K. Nathanson, A. DeMichele, 2014, Genetics in Medicine.

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Marc E. Lenburg, Donald A. Berry, Olufunmilayo I. Olopade, 2011, Breast Cancer Research and Treatment.

Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women

Nandita Mitra, Angela DeMichele, T. Rebbeck, 2013, Breast Cancer Research and Treatment.

Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy

Mitchell D. Schnall, Wensheng Guo, Arjun G. Yodh, 2012, Biomedical optics express.

Neoadjuvant therapy for breast cancer: controversies in clinical trial design and standard of care.

Julia White, Angela DeMichele, A. DeMichele, 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

Nola Hylton, Carolyn Mies, Olufunmilayo I Olopade, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures

Mitchell D. Schnall, So Hyun Chung, Arjun G. Yodh, 2015, Breast Cancer Research.

Cancer Information Scanning and Seeking in the General Population

Katrina Armstrong, Annice Kim, Jeff Niederdeppe, 2010, Journal of health communication.

A genome-wide association study of breast cancer in women of African ancestry

Clement Adebamowo, Olufunmilayo I. Olopade, Gary K. Chen, 2012, Human Genetics.

Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.

Angela DeMichele, Philippe L Bedard, N Lynn Henry, 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Genomic Predictors of Outcome and Treatment Response in Breast Cancer

Angela DeMichele, A. DeMichele, L. Dunn, 2012, Molecular Diagnosis & Therapy.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Anne M Wallace, Michael Hogarth, Lajos Pusztai, 2016, The New England journal of medicine.

Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients.

Katrina Armstrong, Linda Jacobs, Angela DeMichele, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differentiation of benign and malignant breast lesions by in-vivo three-dimensional diffuse optical tomography.

Britton Chance, Arjun G. Yodh, Regine Choe, 2009 .

Differences in information seeking among breast, prostate, and colorectal cancer patients: results from a population-based survey.

Katrina Armstrong, Anca Romantan, Rebekah H Nagler, 2010, Patient education and counseling.

Adult Cancer Survivorship: Evolution, Research, and Planning Care

Angela DeMichele, S. Palmer, M. Hampshire, 2009, CA: a cancer journal for clinicians.

Optically Measured Microvascular Blood Flow Contrast of Malignant Breast Tumors

Mitchell D. Schnall, Arjun G. Yodh, Michael D. Feldman, 2014, PloS one.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Michael Hogarth, Lajos Pusztai, Rita Nanda, 2016, The New England journal of medicine.

Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response1

Bilwaj Gaonkar, Christos Davatzikos, Despina Kontos, 2015, Translational oncology.

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

Anne Wallace, Emanuel F Petricoin, Rita Nanda, 2015, Clinical Cancer Research.